← Back
$MBX All transactions

MBX Biosciences, Inc.

A

$ Value

$0

Shares

35,250

Price

$0

Filed

Feb 3

Insider

Name

Hawryluk P. Kent

Title

President & CEO

CIK

0001673991

Roles

Director Officer

Transaction Details

Transaction Date

2026-02-02

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

699,506

Footnotes

Represents the grant of restricted stock units (RSUs). The RSUs will vest over a four (4) year period in equal quarterly installments, subject to the Reporting Person's continued service on such vesting date. | Shares held by the P. Kent Hawryluk Revocable Trust dated January 25, 2011, of which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose. | The shares underlying this option vest and become exercisable in forty eight (48) equal monthly installments, beginning on March 2, 2026, subject to the Reporting Person's continued service on such vesting date.

Filing Info

Accession No.

0001193125-26-035582

Form Type

4

Issuer CIK

0001776111

Hawryluk P. Kent's History

Date Ticker Type Value
2026-02-26 MBX M $460K
2026-02-26 MBX M $0
2026-02-02 MBX A $0
2026-02-02 MBX A $0
2025-10-24 MBX M $594K
2025-10-24 MBX M $0
2025-10-20 MBX $273K

Other Insiders at MBX (90d)

Insider Bought Sold Last
Hoerter Steven L. 2025-11-22
Hawryluk P. Kent
President & CEO
2026-02-26
Bartram Richard
Chief Financial Officer
2026-02-02
Azoulay Salomon
Chief Medical Officer
2026-02-02